ACM
WST icon

Atlanta Capital Management’s West Pharmaceutical WST Stock Holding History

Atlanta Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-541,697
Closed -$41.1M – 162
2016
Q2 		$41.1M Sell
541,697
-65,379
-11% -$4.76M 0.27% 90
2016
Q1 		$42.1M Sell
607,076
-13,009
-2% -$783K 0.3% 85
2015
Q4 		$37.3M Sell
620,085
-2,543
-0.4% -$153K 0.27% 93
2015
Q3 		$33.7M Buy
622,628
+4,887
+0.8% +$285K 0.25% 107
2015
Q2 		$35.9M Sell
617,741
-13,660
-2% -$762K 0.24% 107
2015
Q1 		$38M Buy
631,401
+41,829
+7% +$2.23M 0.26% 110
2014
Q4 		$31.4M Sell
589,572
-27,106
-4% -$1.36M 0.22% 117
2014
Q3 		$27.6M Buy
616,678
+89,979
+17% +$3.82M 0.2% 119
2014
Q2 		$22.2M Buy
526,699
+59,473
+13% +$2.55M 0.15% 136
2014
Q1 		$20.6M Buy
467,226
+3,594
+0.8% +$169K 0.14% 143
2013
Q4 		$22.7M Buy
463,632
+150,578
+48% +$7.05M 0.15% 139
2013
Q3 		$12.9M Buy
+313,054
New +$11.9M 0.09% 151

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Atlanta Capital Management's WST Position: Q3 2016 in Review

Atlanta Capital Management sold out of West Pharmaceutical (WST) in Q3 2016, closing a stake of 541,697 shares — an estimated $41.1M sold.

Atlanta Capital Management first reported a position in WST in Q3 2013 and held it in 12 quarters. The position peaked at $42.1M in Q1 2016. 280 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • Atlanta Capital Management reported no remaining West Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Atlanta Capital Management sold 541,697 West Pharmaceutical shares in Q3 2016, an estimated $41.1M.
  • Atlanta Capital Management first reported a position in West Pharmaceutical in Q3 2013 and held it in 12 quarters.
  • Atlanta Capital Management's West Pharmaceutical position peaked at $42.1M in Q1 2016.
  • 280 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on Atlanta Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.